Insider Transactions Reported by 18 Insiders of Aprea Therapeutics, Inc.

Symbol
APRE on Nasdaq
Location
Doylestown, PA

Insiders trading volume in the past year

Aprea Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christian S. Schade Director $976,345 28 Jul 2022
Scott M. Coiante SVP, Chief Financial Officer $533,970 28 Jul 2022
Marc Duey Director $299,226 +$25,000 +9.1% 10 Dec 2025
Oren Gilad President/CEO, Director $258,459 +$60,119 +30% 12 Mar 2026
Eyal C. Attar SVP, Chief Medical Officer, Director $211,254 03 Jun 2022
Gregory Alan Korbel SVP, Chief Operating Officer $168,445 28 Jul 2022
Lars B. Abrahmsen SVP, Chief Scientific Officer $160,855 10 Mar 2022
Bernd R. Seizinger Director $74,155 05 Jun 2025
Nadeem Q. Mirza Chief Medical Officer $49,062 01 May 2024
Rifat Pamukcu Director $31,676 05 Jun 2025
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr $25,681 +$10,898 +74% 12 Mar 2026
Michael Aaron Kelly Director $16,969 30 Jun 2021
Fouad Namouni Director $16,969 30 Jun 2021
John B. Henneman III Director $16,570 05 Jun 2025
Richard Peters Director $5,052 05 Jun 2025
Michael Grissinger Director $4,680 05 Jun 2025
Gabriela Gruia Director $1,692 05 Jun 2025
Jean-Pierre Bizzari Director $1,692 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for Aprea Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Oren Gilad APRE Common Stock Award 5.4% 20,175 393,895 12 Mar 2026 Direct
Oren Gilad APRE Stock Options (Right to Buy) Award 80,700 80,700 12 Mar 2026 Direct
John P. Hamill APRE Common Stock Award 30.2% 10,095 43,528 12 Mar 2026 Direct
John P. Hamill APRE Stock Options (Right to Buy) Award 40,380 40,380 12 Mar 2026 Direct
Oren Gilad APRE Common Stock Purchase 8.13% $25,009 $0.8900 28,100 373,720 30 Jan 2026 Direct
Oren Gilad APRE Common Warrant Purchase 28,100 28,100 30 Jan 2026 Direct
John P. Hamill APRE Common Stock Purchase 20.6% $5,073 $0.8900 5,700 33,433 30 Jan 2026 Direct
John P. Hamill APRE Common Warrant Purchase 5,700 5,700 30 Jan 2026 Direct
Marc Duey APRE Common Stock Purchase 9.14% $25,000 $1.16 21,459 256,155 10 Dec 2025 Direct
Marc Duey APRE Common Warrant Purchase 21,459 21,459 10 Dec 2025 Direct
John P. Hamill APRE Common Stock Purchase 22% $5,825 $1.16 5,000 27,733 10 Dec 2025 Direct
John P. Hamill APRE Common Warrant Purchase 5,000 5,000 10 Dec 2025 Direct
Oren Gilad APRE Common Warrants Purchase 21,459 21,459 10 Dec 2025 Direct
Oren Gilad APRE Pre-Funded Warrant Purchase 21,459 21,459 10 Dec 2025 Direct
Bernd R. Seizinger APRE Common Stock Award 2.34% 1,045 45,775 05 Jun 2025 Direct
Bernd R. Seizinger APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
Richard Peters APRE Common Stock Award 50.4% 1,045 3,119 05 Jun 2025 Direct
Richard Peters APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
Rifat Pamukcu APRE Common Stock Award 23.7% 1,045 5,446 05 Jun 2025 Direct
Rifat Pamukcu APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
John B. Henneman III APRE Common Stock Award 11.4% 1,045 10,229 05 Jun 2025 Direct
John B. Henneman III APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
Gabriela Gruia APRE Common Stock Award 1,045 1,045 05 Jun 2025 Direct
Gabriela Gruia APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
Michael Grissinger APRE Common Stock Award 56.7% 1,045 2,889 05 Jun 2025 Direct
Michael Grissinger APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
Marc Duey APRE Common Stock Award 0.45% 1,045 234,696 05 Jun 2025 Direct
Marc Duey APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
Jean-Pierre Bizzari APRE Common Stock Award 1,045 1,045 05 Jun 2025 Direct
Jean-Pierre Bizzari APRE Stock Options (Right to Buy) Award 4,185 4,185 05 Jun 2025 Direct
Oren Gilad APRE Common Stock Purchase 1.62% $10,110 $1.84 5,500 345,620 03 Apr 2025 Direct
John P. Hamill APRE Common Stock Award 17.4% 3,365 22,733 27 Mar 2025 Direct
John P. Hamill APRE Stock Options (Right to Buy) Award 13,460 13,460 27 Mar 2025 Direct
Oren Gilad APRE Common Stock Award 2.02% 6,725 340,120 27 Mar 2025 Direct
Oren Gilad APRE Stock Options (Right to Buy) Award 26,900 26,900 27 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.